Maria Plana

625 total citations
43 papers, 527 citations indexed

About

Maria Plana is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Maria Plana has authored 43 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 14 papers in Cell Biology and 5 papers in Oncology. Recurrent topics in Maria Plana's work include Protein Kinase Regulation and GTPase Signaling (8 papers), RNA regulation and disease (7 papers) and Endoplasmic Reticulum Stress and Disease (7 papers). Maria Plana is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (8 papers), RNA regulation and disease (7 papers) and Endoplasmic Reticulum Stress and Disease (7 papers). Maria Plana collaborates with scholars based in Spain, Italy and Germany. Maria Plana's co-authors include Emilio Itarte, Nerea Roher, Francesc Miró‐Mur, Franc Llorens, Montserrat Pagès, Albert Goday, Ramón Eritja, M. Carmen Martı́nez, Eduard Sarró and Carmen Martos and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Maria Plana

41 papers receiving 514 citations

Peers

Maria Plana
Stacey M. Southall United Kingdom
Karin Mattern Netherlands
Brandon White United States
Janel K. Warmka United States
Jerry L. Hooker United States
Quan Wu China
Dirk Erdmann Switzerland
Stacey M. Southall United Kingdom
Maria Plana
Citations per year, relative to Maria Plana Maria Plana (= 1×) peers Stacey M. Southall

Countries citing papers authored by Maria Plana

Since Specialization
Citations

This map shows the geographic impact of Maria Plana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Plana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Plana more than expected).

Fields of papers citing papers by Maria Plana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Plana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Plana. The network helps show where Maria Plana may publish in the future.

Co-authorship network of co-authors of Maria Plana

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Plana. A scholar is included among the top collaborators of Maria Plana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Plana. Maria Plana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Plana, Maria, Sara Tous, Esther Vilajosana, et al.. (2024). Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma. Frontiers in Oncology. 14. 1458479–1458479.
2.
Vilardell, Jordi, Christian Borgo, Eduard Sarró, et al.. (2020). Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells. PLoS ONE. 15(1). e0227340–e0227340. 11 indexed citations
3.
Antonio, Maite, et al.. (2020). 934P Comparing frailty screening tools for older head and neck cancer patients. Annals of Oncology. 31. S670–S670. 1 indexed citations
4.
Pinna, Lorenzo A., Maria Ruzzene, Emilio Itarte, et al.. (2019). Up-Regulation of the Alpha Prime Subunit of Protein Kinase CK2 as a Marker of Fast Proliferation in GL261 Cultured Cells. Pathology & Oncology Research. 25(4). 1659–1663. 7 indexed citations
5.
Vilardell, Jordi, Eduard Sarró, Thaïs Cuadros, et al.. (2017). Under-expression of CK2β subunit in ccRCC represents a complementary biomarker of p-STAT3 Ser727 that correlates with patient survival. Oncotarget. 9(5). 5736–5751. 15 indexed citations
6.
Ferrer‐Font, Laura, et al.. (2015). Protein Kinase CK2 Content in GL261 Mouse Glioblastoma. Pathology & Oncology Research. 22(3). 633–637. 5 indexed citations
7.
Tornavaca, Olga, Eduard Sarró, Gloria Pascual, et al.. (2011). KAP Degradation by Calpain Is Associated with CK2 Phosphorylation and Provides a Novel Mechanism for Cyclosporine A-Induced Proximal Tubule Injury. PLoS ONE. 6(9). e25746–e25746. 8 indexed citations
8.
Sarró, Eduard, Olga Tornavaca, Maria Plana, Anna Meseguer, & Emilio Itarte. (2007). Phosphoinositide 3-kinase inhibitors protect mouse kidney cells from cyclosporine-induced cell death. Kidney International. 73(1). 77–85. 23 indexed citations
9.
Llorens, Franc, Stefania Sarno, Eduard Sarró, et al.. (2005). Cross talk between protein kinase CK2 and eukaryotic translation initiation factor eIF2β subunit. Molecular and Cellular Biochemistry. 274(1-2). 53–61. 5 indexed citations
10.
Miró‐Mur, Francesc, Franc Llorens, Nerea Roher, et al.. (2002). Persistent nuclear accumulation of protein kinase CK2 during the G1-phase of the cell cycle does not depend on the ERK1/2 pathway but requires active protein synthesis. Archives of Biochemistry and Biophysics. 406(2). 165–172. 3 indexed citations
11.
Roher, Nerea, Francesc Miró‐Mur, Brigitte Boldyreff, et al.. (2001). The C‐terminal domain of human grp94 protects the catalytic subunit of protein kinase CK2 (CK2α) against thermal aggregation. European Journal of Biochemistry. 268(2). 429–436. 16 indexed citations
12.
Roher, Nerea, Stefania Sarno, Francesc Miró‐Mur, et al.. (2001). The carboxy‐terminal domain of Grp94 binds to protein kinase CK2α but not to CK2 holoenzyme. FEBS Letters. 505(1). 42–46. 11 indexed citations
13.
Miró‐Mur, Francesc, Floria Pancetti, Nerea Roher, et al.. (1999). Tumour suppressor protein p53 released by nuclease digestion increases at the onset of rat liver regeneration. Journal of Hepatology. 31(2). 306–314. 4 indexed citations
14.
Roher, Nerea, et al.. (1998). Protein kinase CK2 is altered in insulin‐resistant genetically obese (fa/fa) rats. FEBS Letters. 437(3). 211–215. 4 indexed citations
15.
Trujillo, Ramón, Francesc Miró‐Mur, Maria Plana, et al.. (1997). Substrates for Protein Kinase CK2 in Insulin Receptor Preparations from Rat Liver Membranes: Identification of a 210-kDa Protein Substrate as the Dimeric Form of Endoplasmin. Archives of Biochemistry and Biophysics. 344(1). 18–28. 12 indexed citations
16.
Gil, Carles, Maria Plana, Marta Riera, & Emilio Itarte. (1996). Rat Liver pp49, a Protein That Forms Complexes with Protein Kinase CK2, Is Composed of the β and the γ Subunits of Translation Initiation Factor eIF-2. Biochemical and Biophysical Research Communications. 225(3). 1052–1057. 5 indexed citations
17.
Gil, Carles, Maria Plana, Assumpta Carabaza, et al.. (1996). Differential effect of alkyl chain-modified ether lipids on protein kinase C autophosphorylation and histone phosphorylation. Biochemical Pharmacology. 52(12). 1843–1847. 4 indexed citations
18.
Plana, Maria, Carles Gil, Elena Molina, & Emilio Itarte. (1994). Protein kinase CKII: possible regulation by interaction with protein substrates.. PubMed. 40(5-6). 455–61.
19.
Trujillo, Ramón, et al.. (1991). Dissociation of the hepatic insulin receptor favours its phosphorylation by casein kinase 2. FEBS Letters. 283(1). 15–18. 3 indexed citations
20.
Pérez‐Riba, Mercè, et al.. (1989). Acute effects of insulin and glucagon on hepatic casein kinase 2 in adult fed rats: Correlation of the effects on casein kinase 2 with the changes in glycogen synthase activity. Archives of Biochemistry and Biophysics. 275(2). 478–485. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026